Vaxart, Inc. Profile Avatar - Palmy Investing

Vaxart, Inc.

Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet …

Biotechnology
US, South San Francisco [HQ]

Resulting Ratios

15 Records · Starting from 2009
Loading...
End of VXRT's Analysis
CIK: 72444 CUSIP: 92243A200 ISIN: US92243A2006 LEI: - UEI: -
Secondary Listings
VXRT has no secondary listings inside our databases.